Astec Lifesciences informs about post open offer status

16 Dec 2015

Kotak Mahindra Capital Company (‘Manager to the Offer’), on behalf of Godrej Agrovet (‘Acquirer’) has informed this Post Offer Announcement to the Equity Shareholders of Astec Lifesciences (‘Target Company’), pursuant to and in accordance with regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto (‘SEBI (SAST) Regulations’) in respect of the open offer (‘Offer’) to acquire up to 5,067,259 fully paid up equity shares of Rs 10 each (‘Shares’) of the Target Company. The detailed public statement (‘DPS’) with respect to the Offer was made on September 04, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Astec Lifesciences Ltd. Links:

Astec Lifesciences Share Price

1245.15 -1.70 (-0.14%) Sep 18, 18:01
1 Year Price Chart
Peers
Company Name CMP
UPL 537.85
BASF India 1512.40
Bayer CropScience 6368.75
PI Industries 2037.60
Rallis India 300.90
View more..
Sensex vs Astec Lifesciences
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback